Efficient expression of fusion human epidermal growth factor in tobacco chloroplasts
Open Access
- 7 January 2023
- journal article
- research article
- Published by Springer Nature in BMC Biotechnology
- Vol. 23 (1) , 1-9
Abstract
Background: Chloroplast transformation is a robust technology for the expression of recombinant proteins. Various types of pharmaceutical proteins including growth factors have been reported in chloroplasts via chloroplast transformation approach at high expression levels. However, high expression of epidermal growth factor (EGF) in chloroplasts with the technology is still unavailable. Results: The present work explored the high-level expression of recombinant EGF, a protein widely applied in many clinical therapies, in tobacco chloroplasts. In this work, homoplastic transgenic plants expressing fusion protein GFP-EGF, which was composed of GFP and EGF via a linker, were generated. The expression of GFP-EGF was confirmed by the combination of green fluorescent observation and Western blotting. The achieved accumulation of the recombinant fusion GFP-EGF was 10.21 ± 0.27% of total soluble proteins (1.57 ± 0.05 g kg− 1 of fresh leaf). The chloroplast-derived GFP-EGF was capable of increasing the cell viability of the NSLC cell line A549 and enhancing the phosphorylation level of the EGF receptor in the A549 cells. Conclusion: The expression of recombinant EGF in tobacco chloroplasts via chloroplast transformation method was achieved at considerable accumulation level. The attempt gives a good example for the application of chloroplast transformation technology in recombinant pharmaceutical protein production.Keywords
Funding Information
- Natural Science Foundation of Jilin Academy of Agricultural Sciences (KYJF2021ZR106)
- Agricultural Innovation Project of Jilin Province (CXGC2017TD004)
This publication has 67 references indexed in Scilit:
- Transformation of alfalfa chloroplasts and expression of green fluorescent protein in a forage cropBiotechnology Letters, 2011
- Chloroplast‐derived vaccines against human diseases: achievements, challenges and scopesPlant Biotechnology Journal, 2011
- Eukaryotic protein production in designed storage organellesBMC Biology, 2009
- Epidermal growth factor therapy and wound healing — past, present and future perspectivesThe Surgeon, 2008
- Expression and characteristic of synthetic human epidermal growth factor (hEGF) in transgenic tobacco plantsBiotechnology Letters, 2007
- Accumulation of hEGF and hEGF–fusion proteins in chloroplast-transformed tobacco plants is higher in the dark than in the lightJournal of Biotechnology, 2006
- Expression of active human epidermal growth factor (hEGF) in tobacco plants by integrative and non-integrative systemsMolecular Breeding, 2004
- Engineered GFP as a vital reporter in plantsCurrent Biology, 1996
- Expression of a Chemically Synthesized Gene for Human Epidermal Growth Factor under the Control of Cauliflower Mosaic Virus 35S Promoter in Transgenic TobaccoBioscience, Biotechnology, and Biochemistry, 1993
- [6] Use of T7 RNA polymerase to direct expression of cloned genes1990